XB628
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for XB628, covering 2025-12-26 to 2025-12-26. Get the full timeline:
Most recent: Clinical Trial Update: A Study of XB628 in Participants With Recurrent Advanced or Metastatic Solid Tumors [Phase 1]